Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001529371-26-000008

Director sold 131,210 shares at $9.50 ($1,246,941)

  • Director acquired 55,979 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cohen Cheryl · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-02 Exercise or conversion : show line 1 in the form 10b5-1 +55,979 $2.98 $166,817 256,596 D
2026-07-02 Sale : show line 2 in the form 10b5-1 −131,210 $9.50 $1,246,941 125,386 D
Open-market sales · 131,210 sh · avg $9.50 · $1,246,941

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-02 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −55,979 111,958 D
Loading xslF345X06/wk-form4_1783383979.xml…